Nadifloxacin | CAS 124858-35-1 - Request Quote
Nadifloxacin
| SZ CAT No: | SZ-N042001 |
| CAS No | 124858-35-1 |
| Mol.F. | C19H21FN2O4 |
| Mol.Wt. | 360.4 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 86826-12-2 (Na salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nadifloxacin is chemically 9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid. Nadifloxacin is supplied with detailed characterization data compliant with regulatory guideline. Nadifloxacin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nadifloxacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 124858-35-1
Purchase 124858-35-1
Order 124858-35-1
Enquire 124858-35-1
price of 124858-35-1
124858-35-1 Supplier
124858-35-1 Manufacturer
124858-35-1 Exporter
buy high quality Nadifloxacin
Purchase Nadifloxacin
Nadifloxacin suppliers
Nadifloxacin manufacturers
Nadifloxacin price
Order Nadifloxacin
Enquire Nadifloxacin
Nadifloxacin cost
Nadifloxacin Supplier
Nadifloxacin Distributor
Nadifloxacin for Method Validation
Nadifloxacin Reference Standard
Nadifloxacin for ANDA Filing
Nadifloxacin for Forced Degradation Studies
Nadifloxacin Identification Standards
Nadifloxacin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.